The field of immuno-oncology continues to evolve at a rapid pace. With the emergence of novel therapies, such as vaccines, and novel combinations and treatment sequencing, the impact of immunotherapy on the oncology clinical cannot be undervalued. However, there are still many hurdles that must be overcome in order to maximise the success of immuno-oncology.
To kick start this Spotlight, Oncology Central has put together a survey that explores the clinical applications, challenges and the future of immuno-oncology. You can complete the short survey on immuno-oncology here and get a 6-month free subscription to Immunotherapy and/ or Future Oncology. We’d really value your input and look forward to sharing key trends later in the Spotlight.